Latest Developments in Global Subdermal Contraceptive Implants Market

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Latest Developments in Global Subdermal Contraceptive Implants Market

  • Healthcare
  • Upcoming Report
  • Oct 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In February 2024, Bayer AG partnered with DARÉ BIOSCIENCE to enhance the development of an innovative hormone-free monthly contraceptive option. This collaboration aims to address the growing demand for non-hormonal contraceptive methods, providing consumers with more choices in family planning. By combining their expertise, the two companies seek to advance reproductive health solutions and improve accessibility to effective contraceptive alternatives
  • In February 2023, the Family Planning Association of India (FPAI) launched efforts to promote Implanon NXT, a new contraceptive option. This subdermal single-rod implant offers a long-term, reversible contraceptive solution, providing a modern alternative to older implant types such as Norplant, Jadelle, Sino-implant, and the original Implanon. By advocating for Implanon NXT, FPAI aims to enhance reproductive health choices and improve accessibility to effective family planning methods
  • In April 2022, ProMed unveiled the start of preclinical evaluations for resorbable contraceptive implants, a pioneering project backed by the Bill & Melinda Gates Foundation. This initiative focuses on developing cutting-edge contraceptive options that enhance patient safety and comfort, addressing the needs of diverse populations. With the foundation's significant support, ProMed aims to drive forward research and innovation in reproductive health, potentially transforming contraceptive choices for individuals worldwide

Frequently Asked Questions

The market is segmented based on Segmentation, By Type (Etonogestrel Implant, Levonorgestrel Implant, and Others), Application (Hospital, Clinic, and Research Facilities) – Industry Trends and Forecast to 2031 .
The Global Subdermal Contraceptive Implants Market size was valued at USD 878.13 USD Million in 2023.
The Global Subdermal Contraceptive Implants Market is projected to grow at a CAGR of 3.32% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..